Clinical Trial Update: Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the impact of intravesical BCG and gemcitabine on semen quality and testicular volume in urothelial carcinoma of the bl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma of the Bladder

Drugs mentioned

• BCG (intravesical)
• Gemcitabine intravesical (Gemcitabine)

Snippet

Sponsor: Assiut University | Conditions: Urothelial Carcinoma Bladder, Sperm Count, Low | Phase 4 | Status: UNKNOWN